openPR Logo

Press Releases from Treprostinil Market (1 total)

Global Treprostinil Market Outlook 2017-2022 United Therapeutics, Bayer Schering …

Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin. Treprostinil is a stable, long-acting prostacyclin analogue which can be administered as a continuous subcutaneous infusion using a portable miniature delivery system. Subcutaneous treprostinil has been shown in a large multicenter randomized controlled trial to improve exercise capacity, clinical state, functional class, pulmonary hemodynamics, and quality of life in

Go To Page:   1 2 3 4 5 6 7 8 9 10